DGFT extends MIP restriction on ATS-8, Sulfadiazine API MIP till November 30, 2026; Extends RELIEF Component II timelines Till March 31, 2027
Sep 30, 2026
|
Simply Register/Sign In to access the free content across the portals!
Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals